Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDR
Zhicai Wu(United States Military Academy), Kenneth A. Thomas(United States Military Academy), Mildred L. Kaufman(United States Military Academy), Jennifer M. Shipman(Johns Hopkins University), George D. Hartman(Joint BioEnergy Institute), Mark E. Fraley(United States Military Academy), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Kathleen Coll(United States Military Academy), Mark T. Bilodeau(Kettering University), Adrienne E. Balitza(United States Military Academy), Bin Shi(Fujian Medical University), Keith Rickert(United States Military Academy), Edward S. Tasber(United States Military Academy)
Cited by 42
Related Papers
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogues
|Journal of the American Chemical Society|1999|463
Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
|Proceedings of the National Academy of Sciences|1996|409
A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines.
|PubMed|1995|385
Micro RNA 145 Targets the Insulin Receptor Substrate-1 and Inhibits the Growth of Colon Cancer Cells
|Journal of Biological Chemistry|2007|356